BeOne Medicines Ltd. financial data

Symbol
ONC on Nasdaq, BEIGF on OTC
Location
Basel
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 204% % -1.8%
Quick Ratio 23% % 1.6%
Debt-to-equity 74% % 9.4%
Return On Assets 1.1% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,438,553,263 shares 3.8%
Common Stock, Shares, Outstanding 1,438,083,590 shares 3.8%
Common Stock, Value, Issued $144,000 USD 4.3%
Weighted Average Number of Shares Outstanding, Basic 1,432,801,699 shares 4.1%
Weighted Average Number of Shares Outstanding, Diluted 1,488,750,354 shares 8.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $4,972,687,000 USD 50%
Research and Development Expense $2,072,457,000 USD 8.8%
Costs and Expenses $4,103,333,000 USD 12%
Operating Income (Loss) $182,676,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $182,262,000 USD
Income Tax Expense (Benefit) $113,712,000 USD 83%
Net Income (Loss) Attributable to Parent $68,550,000 USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,036,868,000 USD 49%
Accounts Receivable, after Allowance for Credit Loss, Current $863,281,000 USD 52%
Inventory, Net $531,687,000 USD 23%
Assets, Current $5,664,477,000 USD 45%
Property, Plant and Equipment, Net $1,628,114,000 USD 4.2%
Operating Lease, Right-of-Use Asset $140,217,000 USD 39%
Other Assets, Noncurrent $136,197,000 USD -32%
Assets $7,632,586,000 USD 31%
Accounts Payable, Current $383,676,000 USD 25%
Employee-related Liabilities, Current $234,298,000 USD 11%
Accrued Liabilities, Current $1,001,661,000 USD 40%
Liabilities, Current $2,368,425,000 USD 17%
Deferred Income Tax Liabilities, Net $47,066,000 USD 195%
Operating Lease, Liability, Noncurrent $51,387,000 USD 58%
Other Liabilities, Noncurrent $64,056,000 USD 27%
Liabilities $3,503,260,000 USD 46%
Accumulated Other Comprehensive Income (Loss), Net of Tax $101,257,000 USD -21%
Retained Earnings (Accumulated Deficit) $8,386,405,000 USD 0.81%
Stockholders' Equity Attributable to Parent $4,129,326,000 USD 20%
Liabilities and Equity $7,632,586,000 USD 31%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares, Issued 1,540,975,898 shares 11%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,110,542,000 USD 51%
Depreciation $146,244,000 USD 5.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $50,818,000 USD
Property, Plant and Equipment, Gross $1,984,495,000 USD 52%
Operating Lease, Liability, Current $15,732,000 USD -11%
Unrecognized Tax Benefits $22,003,000 USD 25%
Additional Paid in Capital $12,616,844,000 USD 5.4%
Amortization of Intangible Assets $9,704,000 USD 47%
Share-based Payment Arrangement, Expense $494,572,000 USD 16%